Investor's Business Daily on MSN
Vertex pops on 'remarkable' results for chronic kidney disease drug
Vertex stock popped late Monday on promising test results for a drug that could treat a chronic autoimmune disease that destroys the kidneys.
Patients with IgA nephropathy had an elevated risk for adverse kidney outcomes starting at proteinuria levels of 0.5 g/g. In patients with immunoglobulin A nephropathy (IgAN), higher levels of ...
Persistent swelling in eyes, feet, hands, or abdomen may signal kidney disease seek medical advice for timely diagnosis and ...
Please provide your email address to receive an email when new articles are posted on . Remission of proteinuria to less than 0.3 g per day was linked to greater eGFR preservation for patients with ...
Background: Among patients with focal segmental glomerulosclerosis (FSGS), proteinuria and kidney function decline may be associated with increased economic burden. This study aimed to provide current ...
Autosomal dominant polycystic kidney disease (ADPKD) is a frequently occurring inherited condition characterised by the formation of multiple cysts and considerable enlargement of both kidneys. The ...
High-protein diets are a frequent topic in clinics, sparking concerns about kidney harm for some and perceived benefits for others. The reality is nuanced, with the source and quantity of protein, as ...
Low-grade proteinuria (< 1 g/24 h) did not predict better renal outcomes or treatment response in patients with lupus nephritis, despite being associated with milder disease phenotypes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results